Serotonin transporter protein polymorphism in the pharmacogenetics of diarrhea-predominant irritable bowel syndrome (D-IBS)

被引：0
|
作者：
Camilleri, M
Atanasova, E
Carlson, PJ
Ahmad, U
Viramontes, BE
McKinzie, S
Urrutia, R
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
501
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [1] Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome
    Camilleri, M
    Atanasova, E
    Carlson, PJ
    Ahmad, U
    Kim, HJ
    Viramontes, BE
    McKinzie, S
    Urrutia, R
    GASTROENTEROLOGY, 2002, 123 (02) : 425 - 432
  • [2] Gender differences in placebo response in patients with diarrhea-predominant irritable bowel syndrome (D-IBS)
    Ameen, VZ
    Heath, AT
    Chang, L
    GASTROENTEROLOGY, 2005, 128 (04) : A463 - A463
  • [3] Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (D-IBS).
    Viramontes, B
    McKinzie, S
    Pardi, DS
    Burton, D
    Thomforde, GM
    Camilleri, M
    GASTROENTEROLOGY, 2000, 118 (04) : A848 - A848
  • [4] Alosetron is safe and effective for the long term treatment of men with diarrhea-predominant irritable bowel syndrome (D-IBS)
    Frissora, CL
    Harris, LA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S278 - S279
  • [5] Safety and efficacy of crofelemer in patients with diarrhea predominant irritable bowel syndrome (D-IBS)
    Lembo, Anthony J.
    Rosenbaum, David P.
    Chey, William D.
    Drossman, Douglas A.
    GASTROENTEROLOGY, 2007, 132 (04) : A141 - A141
  • [6] Symptom severity in women with diarrhea-predominant IBS (D-IBS)
    Ameen, VZ
    Gordon, SH
    Heath, AT
    Carter, EG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S275 - S275
  • [7] Clonidine in diarrhea-predominant irritable bowel syndrome (D-IBS): A randomized, placebo-controlled, dose-response study
    Camilleri, M
    Kim, DY
    McKinzie, S
    Kim, HJ
    Burton, DD
    Thomforde, GM
    Zinsmeister, AR
    GASTROENTEROLOGY, 2002, 122 (04) : A59 - A59
  • [8] Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)
    Smalley, Walter
    Falck-Ytter, Corinna
    Carrasco-Labra, Alonso
    Wani, Sachin
    Lytvyn, Lyubov
    Falck-Ytter, Yngve
    GASTROENTEROLOGY, 2019, 157 (03) : 858 - 858
  • [9] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [10] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
12345